HOME >> BIOLOGY >> NEWS
GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product

GroPep Limited (ASX: GRO) has today announced that a seventh biopharmaceutical product that uses the Company's Cell Culture Products in its manufacturing process, has obtained regulatory approval by the Food and Drug Administration (FDA) in the United States.

An application to market the product in the European Union has also been submitted, for which approval is expected in 2006.

Confidentiality agreements prevent GroPep from naming the specific product or company.

While this approval is not likely to generate significant revenue growth for GroPep, CEO Mr Bob Finder said that the approval is further evidence of the growing international recognition of the superiority of GroPep's Cell Culture Products in the manufacturing of certain biopharmaceutical products.


'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
2-Jun-2005


Page: 1

Related biology news :

1. GroPep infertility data presented at US meeting
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
4. ESA announces 2007 award recipients
5. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
6. Conservation Leadership Program announces 2007 awardees
7. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
8. Revolutionary global environment fund announces $50M expansion
9. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
10. Cell Press announces new partnership with the American Society of Human Genetics
11. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2020)... ... 15, 2020 , ... The National Institutes of Health (NIH) has selected McBee ... Maryland and Tysons Corner, Virginia, to provide patent legal services under two separate ten ... field of chemistry. The firm is one of nine firms in the nation awarded ...
(Date:5/14/2020)... (PRWEB) , ... May 13, 2020 , ... ... launch of Bonlacta™, its latest enzyme for the lactose-free dairy market. This unique ... wide range of lactose-free dairy products at competitive costs across North America. , ...
(Date:5/11/2020)... , ... May 11, 2020 , ... ... monitoring software platform for patients with implanted cardiac devices. The Octagos software allows ... one portal. The software greatly simplifies the management of remote transmissions and at ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... 29, 2020 , ... The Conference Forum is pleased to ... to the unique role of the Chief Medical Officer in the biotech industry. ... best practices and career development of CMOs and Heads of R&D from different ...
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, today ... and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... the new distribution partner for all personal care ingredients in Russia and Belarus. ... DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product line ...
Breaking Biology Technology:
Cached News: